JP5297375B2 - 癌の診断及び治療のための方法及び組成物 - Google Patents

癌の診断及び治療のための方法及び組成物 Download PDF

Info

Publication number
JP5297375B2
JP5297375B2 JP2009520981A JP2009520981A JP5297375B2 JP 5297375 B2 JP5297375 B2 JP 5297375B2 JP 2009520981 A JP2009520981 A JP 2009520981A JP 2009520981 A JP2009520981 A JP 2009520981A JP 5297375 B2 JP5297375 B2 JP 5297375B2
Authority
JP
Japan
Prior art keywords
myb
antibody
gene
sample
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2009520981A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010500869A5 (https=
JP2010500869A (ja
Inventor
ジョン チャント，
アンソニー エス． ゲレロ，
ピーター ハヴァティ，
シンシア ホンチェル，
ケニス ユング，
トーマス ディー． ウー，
Original Assignee
ジェネンテック， インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ジェネンテック， インコーポレイテッド filed Critical ジェネンテック， インコーポレイテッド
Publication of JP2010500869A publication Critical patent/JP2010500869A/ja
Publication of JP2010500869A5 publication Critical patent/JP2010500869A5/ja
Application granted granted Critical
Publication of JP5297375B2 publication Critical patent/JP5297375B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
JP2009520981A 2006-07-19 2007-07-18 癌の診断及び治療のための方法及び組成物 Expired - Fee Related JP5297375B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80779406P 2006-07-19 2006-07-19
US60/807,794 2006-07-19
PCT/US2007/073811 WO2008011482A2 (en) 2006-07-19 2007-07-18 Methods and compositions for the diagnosis and treatment of cancer

Publications (3)

Publication Number Publication Date
JP2010500869A JP2010500869A (ja) 2010-01-14
JP2010500869A5 JP2010500869A5 (https=) 2010-09-09
JP5297375B2 true JP5297375B2 (ja) 2013-09-25

Family

ID=38957597

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009520981A Expired - Fee Related JP5297375B2 (ja) 2006-07-19 2007-07-18 癌の診断及び治療のための方法及び組成物

Country Status (8)

Country Link
US (2) US20100028365A1 (https=)
EP (1) EP2041320B1 (https=)
JP (1) JP5297375B2 (https=)
AT (1) ATE502123T1 (https=)
CA (1) CA2658319A1 (https=)
DE (1) DE602007013234D1 (https=)
ES (1) ES2361950T3 (https=)
WO (1) WO2008011482A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110030074A1 (en) * 2007-05-21 2011-02-03 Dana Farber Cancer Institute, Inc. Compositions and methods for cancer gene discovery
WO2012135696A2 (en) * 2011-04-01 2012-10-04 University Of South Alabama Methods and compositions for the diagnosis, classification, and treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999047152A2 (en) * 1998-03-20 1999-09-23 Sloan Kettering Institute For Cancer Research Use of dipeptidyl peptidase (dpp4) of fibroblast activating protein alpha for suppressing the malignant phenotype of cancer cells
US20030049203A1 (en) * 2001-08-31 2003-03-13 Elmaleh David R. Targeted nucleic acid constructs and uses related thereto

Also Published As

Publication number Publication date
WO2008011482A3 (en) 2008-04-03
CA2658319A1 (en) 2008-01-24
EP2041320B1 (en) 2011-03-16
WO2008011482A2 (en) 2008-01-24
EP2041320A2 (en) 2009-04-01
DE602007013234D1 (de) 2011-04-28
US20130317082A1 (en) 2013-11-28
US20100028365A1 (en) 2010-02-04
JP2010500869A (ja) 2010-01-14
ATE502123T1 (de) 2011-04-15
ES2361950T3 (es) 2011-06-24

Similar Documents

Publication Publication Date Title
US8945572B2 (en) Methods and compositions for the diagnosis and treatment of cancer
AU2006340769A1 (en) Method for diagnosing, prognosing and treating glioma
IL187343A (en) Preparations and methods for diagnosing and treating the tumor
JP2018086000A (ja) 薬剤耐性に関連する遺伝的変異
JP2012177698A (ja) 癌の予後予測方法、診断方法及び治療方法
JP5297375B2 (ja) 癌の診断及び治療のための方法及び組成物
US20150376289A1 (en) Methods and compositions for the diagnosis and treatment of cancer
HK1108924B (en) Cancer prognostic methods

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100720

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100720

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110627

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120724

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20121001

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20121009

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130123

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20130521

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20130614

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees